The CLF4 addresses early to moderate facial ageing: a flattening brow, softening cheek contour, fine forehead lines and the first loosening along the jaw and neck. Its natural audience is clients who dislike needles, cannot accept bruising or recovery days, or want to delay injectables for a few years. It also fits clients already having injectables who want a complementary treatment between appointments, and men looking for discreet facial care that leaves no visible trace. Each of these groups values comfort and a quick return to normal life, which is exactly what this treatment offers.
Research on combined facial stimulation and synchronised radio frequency is growing but remains small in scale. A 2025 study in Asian patients reported an average lift of 1 to 2 mm in the treated areas on 3D measurement, alongside improvements in skin quality. An earlier study of 21 subjects found an average 23% lift at the brows and cheeks three months after treatment. These studies used another manufacturer's system and lacked sham-treated comparison groups, so they indicate what the technique can achieve and cannot stand in for CLF4-specific data.
Aesthetic clinics, medical spas, dermatology practices with a cosmetic list and premium salons with experienced therapists are the likeliest buyers. Practices already offering skincare facials can add it as a premium upgrade, since the client lies in the same position and the room needs no changes. Groups buying through formal procurement routes will ask for device paperwork before installation. The conformity documentation those procurement routes require is issued by the manufacturer and shared by the enquiry team.



